Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2022

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022

Posted on February 14, 2022 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, has released its Q3 financial results and business updates. The company noted that, for the three-month period ending … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Study Shows Mullen FIVE Scores Strong Against Tesla (NASDAQ: TSLA), Ford (NYSE: F) Models

Posted on February 14, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released results of a market study comparing the Mullen FIVE to two industry-leading competitors: the Tesla (NASDAQ: TSLA) Model Y and Ford (NYSE: F) Mach-E. Mullen commissioned the detailed … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Posted on February 14, 2022 by MissionIR

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference

Posted on February 14, 2022 by MissionIR

NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022 Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billion NMRD’s sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives IRB Approval for Kernel Flow Feasibility Study

Posted on February 14, 2022 by MissionIR

Institution Review Board gives green light to study designed around Kernel’s quantitative neuroimaging technology Kernel Flow device provides ability to measure longitudinal brain activity before, during and after a psychedelic experience CYBN CEO says results from study will further support … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions

Posted on February 11, 2022 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth

Posted on February 11, 2022 by MissionIR

Nemaura Medical (NASDAQ: NMRD) recently appointed Dr. Arash Ghadar as its chief operating officer. Dr. Ghadar brings decades of health care and technical experience to Nemaura, including from his previous role as technical director at Datalink Electronics and his current … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ‘Medically Speaking’ Providing Evidence-Based Information, Offering Creative Solutions

Posted on February 11, 2022 by MissionIR

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently launched a new YouTube series, ‘Medically Speaking,’ intended to promote education and offer consumers the necessary resources to help them attain their plant-based objectives. The episodes will focus the conversation … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Host CBD and the Global Market Webinar

Posted on February 11, 2022 by MissionIR

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, has announced that it will hold a webinar today, Feb.11, at 1:00 p.m. ET. The CBD and the Global Market webinar will be the first of the … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Shows Promise in Improving Performance, Speed of ED Drugs

Posted on February 11, 2022 by MissionIR

Health and wellness drug bio-effectiveness innovator Lexaria Bioscience is advancing human testing of its patented DehydraTECH(TM) technology for the potential treatment of high blood pressure and heart disease  Lexaria also recently announced that DehydraTECH boosted the speed and effectiveness of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment